✦ LIBER ✦

Antagonists of growth hormone-releasing hormone (GH-RH) enhance tumour growth inhibition induced by androgen deprivation in human MDA-Pca-2b prostate cancers

✍ Scribed by M. Letsch; A.V. Schally; A. Stangelberger; K. Groot; J.L. Varga

Book ID: 116428020
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 247 KB
Volume: 40
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2003.10.010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhibition of PC-3 human prostate cancer

Inhibition of PC-3 human prostate cancers by analogs of growth hormone-releasing hormone (GH-RH) endowed with vasoactive intestinal peptide (VIP) antagonistic activity

✍ Artur Plonowski; Jozsef L. Varga; Andrew V. Schally; Magdalena Krupa; Kate Groot 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 202 KB

## Abstract Vasoactive intestinal peptide (VIP) stimulates the proliferation and invasiveness of malignant prostatic cells. Receptors for VIP and the closely related growth hormone‐releasing hormone (GH‐RH) show considerable homology and are found in prostatic and other carcinomas. Among various an

Inhibition of in vivo proliferation of M

Inhibition of in vivo proliferation of MDA-PCa-2b human prostate cancer by a targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207

✍ Artur Plonowski; Andrew V Schally; Attila Nagy; Kate Groot; Magdalena Krupa; Nor 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 118 KB

Inhibition of human androgen-independent

Inhibition of human androgen-independent PC-3 and DU-145 prostate cancers by antagonists of bombesin and growth hormone releasing hormone is linked to PKC, MAPK and c-jun intracellular signalling

✍ Anton Stangelberger; Andrew V. Schally; Jozsef L. Varga; Marta Zarandi; Ren-Zhi 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 279 KB